MedPath

The Empowerment Model Towards Type 2 Diabetic Adults To Enhance Vegetable Intake in Achieving Glycemic Control

Phase 2
Completed
Conditions
Glycemic Control for Diabetes Mellitus
Interventions
Other: Control group following conventional approach
Behavioral: Empowerment model to improve dietary intake
Registration Number
NCT01828242
Lead Sponsor
SEAMEO Regional Centre for Food and Nutrition
Brief Summary

Life style changes, particularly in dietary patterns have contributed a great deal to the incidence and risks of type 2 Diabetes. Decreased intakes of vegetables and fruits replaced by pre processed food, added sugar and those of animal origin lead towards rapid increase of adult-onset-diabetes.

In spite of the knowledge of the benefit of consuming vegetable and fruits, and people are well informed, they still need to be committed to perform a behavior and implement these intention. Behavioral approach methods have demonstrated successful adherence in health education with life style changes.

Objective: To identify the impact of The Empowerment Model to enhance vegetable intake in Type 2 Diabetes Mellitus adults in achieving glycemic control.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • fasting blood glucose ≥126 mg/dL
  • HbA1C >8%
Exclusion Criteria
  • those who have serious, unstable medical conditions, or related to metabolic disorders (i.e. thyroid diseases)
  • significant co-morbid illnesses such as liver disease, kidney disease, cancer, bowel diseases/ malfunction, pregnancy or nursing mothers.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control group following conventional approachControl group following conventional approachControl group following conventional approach
Empowerment model to DiabetesEmpowerment model to improve dietary intakeEmpowerment model to improve dietary intake
Primary Outcome Measures
NameTimeMethod
HbA1CBaseline (week 0), Endline (week 12)
Secondary Outcome Measures
NameTimeMethod
Post Prandial blood glucoseDaily for 12 weeks
Fasting Blood GlucoseDaily for 12 weeks

Trial Locations

Locations (1)

Telecommunication Company

🇮🇩

Jakarta, Indonesia

© Copyright 2025. All Rights Reserved by MedPath